Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP

PHASE4CompletedINTERVENTIONAL
Enrollment

449

Participants

Timeline

Start Date

February 5, 2020

Primary Completion Date

October 30, 2022

Study Completion Date

October 30, 2022

Conditions
HIV InfectionsHIV/AIDSNeisseria Gonorrheae InfectionChlamydia Trachomatis InfectionSyphilis Infection
Interventions
DRUG

Doxycycline

200 mg of doxycycline to be taken orally within 24 hours and up to 72 hours after each condomless sex act

Trial Locations (1)

Unknown

Kenya Medical Research Institute, Kisumu

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

collaborator

Kenya National AIDS & STI Control Programme

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Washington

OTHER